A detailed history of Bryn Mawr Trust CO transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 52,054 shares of TMO stock, worth $27.5 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
52,054
Previous 47,501 9.59%
Holding current value
$27.5 Million
Previous $26.3 Million 22.57%
% of portfolio
0.59%
Previous 1.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$531.86 - $624.21 $2.42 Million - $2.84 Million
4,553 Added 9.59%
52,054 $32.2 Million
Q2 2024

Aug 08, 2024

SELL
$541.52 - $599.02 $248,557 - $274,950
-459 Reduced 0.96%
47,501 $26.3 Million
Q1 2024

May 14, 2024

SELL
$528.82 - $599.43 $401,374 - $454,967
-759 Reduced 1.56%
47,960 $27.9 Million
Q3 2023

Nov 15, 2023

SELL
$498.29 - $574.41 $195,827 - $225,743
-393 Reduced 0.8%
48,719 $24.7 Million
Q2 2023

Aug 11, 2023

SELL
$508.46 - $591.13 $536,933 - $624,233
-1,056 Reduced 2.1%
49,112 $25.6 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $1.18 Million - $1.33 Million
-2,202 Reduced 4.2%
50,168 $28.9 Million
Q4 2022

Feb 10, 2023

SELL
$484.71 - $571.37 $3.77 Million - $4.44 Million
-7,770 Reduced 12.92%
52,370 $28.8 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $407,780 - $486,009
-804 Reduced 1.32%
60,140 $30.5 Million
Q2 2022

Aug 11, 2022

SELL
$500.9 - $612.21 $1.18 Million - $1.45 Million
-2,361 Reduced 3.73%
60,944 $33.1 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $1.48 Million - $1.82 Million
-2,819 Reduced 4.26%
63,305 $37.4 Million
Q4 2021

Feb 10, 2022

SELL
$569.0 - $667.24 $645,815 - $757,317
-1,135 Reduced 1.69%
66,124 $44.1 Million
Q3 2021

Oct 26, 2021

SELL
$509.53 - $609.78 $1.02 Million - $1.22 Million
-2,004 Reduced 2.89%
67,259 $38.4 Million
Q2 2021

Jul 29, 2021

SELL
$441.0 - $508.24 $41,454 - $47,774
-94 Reduced 0.14%
69,263 $34.9 Million
Q1 2021

Apr 23, 2021

SELL
$439.85 - $518.83 $292,060 - $344,503
-664 Reduced 0.95%
69,357 $31.7 Million
Q4 2020

Feb 11, 2021

SELL
$435.06 - $527.66 $7.08 Million - $8.59 Million
-16,285 Reduced 18.87%
70,021 $32.6 Million
Q3 2020

Nov 12, 2020

SELL
$359.77 - $441.52 $1.29 Million - $1.58 Million
-3,581 Reduced 3.98%
86,306 $38.1 Million
Q2 2020

Aug 13, 2020

SELL
$275.2 - $362.34 $3.43 Million - $4.51 Million
-12,449 Reduced 12.16%
89,887 $32.6 Million
Q1 2020

May 08, 2020

SELL
$255.3 - $340.05 $143,223 - $190,768
-561 Reduced 0.55%
102,336 $29 Million
Q4 2019

Feb 11, 2020

BUY
$271.93 - $328.04 $275,465 - $332,304
1,013 Added 0.99%
102,897 $33.4 Million
Q3 2019

Oct 24, 2019

SELL
$268.46 - $305.43 $41,074 - $46,730
-153 Reduced 0.15%
101,884 $29.7 Million
Q2 2019

Aug 15, 2019

SELL
$257.51 - $295.55 $3.74 Million - $4.3 Million
-14,543 Reduced 12.47%
102,037 $30 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $2,121 - $2,737
10 Added 0.01%
116,580 $31.9 Million
Q4 2018

Feb 15, 2019

SELL
$208.47 - $251.98 $155,518 - $187,977
-746 Reduced 0.64%
116,570 $26.1 Million
Q3 2018

Nov 15, 2018

SELL
$205.57 - $244.32 $102,168 - $121,427
-497 Reduced 0.42%
117,316 $28.6 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $417,858 - $451,573
-2,057 Reduced 1.72%
117,813 $24.4 Million
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $423,205 - $491,473
-2,193 Reduced 1.8%
119,870 $24.7 Million
Q4 2017

Feb 15, 2018

BUY
$182.03 - $200.37 $122,142 - $134,448
671 Added 0.55%
122,063 $23.2 Million
Q3 2017

Aug 28, 2019

SELL
$171.74 - $194.04 $72,989 - $82,467
-425 Reduced 0.35%
121,392 $23 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $20.9 Million - $23.6 Million
121,817
121,817 $23 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.